Effects of platelet factor 4 on expression of bone marrow heparan sulfate in syngenic bone marrow transplantation mice

被引:0
作者
Meng Fankai
Sun Hanying
Liu Wenli
Yuan Huiling
Xu Huizhen
Sun Lan
Zhou Yinli
Ren Tianhua
机构
[1] Huazhong University of Science and Technology,Department of Hematology, Tongji Hospital, Tongji Medical College
关键词
platelet factor 4; bone marrow transplantation; heparan sulfate;
D O I
10.1007/BF02828176
中图分类号
学科分类号
摘要
To explore the effects of platelet factor 4 (PF4) on hematopoietic reconstitution and its mechanism in syngenic bone marrow transplanation (BMT). The syngenic BMT mice models were established. 20 and 26 h before irradiation, the mice were injected 20 μg/kg PF4 or PBS twice into abdominal cavity, then the donor bone marrow nuclear cells (BMNC) were transplanted. On the 7th day, spleen clone forming units (CFU-S) were counted. On the 7th, 14th and 21st day after BMT, the BMNC and megakaryoryocytes in bone marrow tissue were counted and the percentage of hematopoietic tissue and expression level of heparan sulfate in bone marrow tissue were assessed. In PF4-treated groups, the CFU-S counts on the 7th day were higher than those in BMT groups after BMT. The BMNC and megakaryoryocyte counts and the percentage of hematopoietic tissue and heparan sulfate expression level were higher than those in BMT group on the 7th, 14th and 21st day after BMT (P<0.01 orP<0.05). PF4 could accelerate hematopoietic reconstitution of syngenic bone marrow transplantation. The promotion of the heparan sulfate expression in bone marrow may be one of mechanisms of PF4.
引用
收藏
页码:190 / 192
页数:2
相关论文
共 20 条
[1]  
Xi X(2002)Direct and reversible inhibition of platelet factor 4 on megakaryocyte development from CD34 Br J Haematol 93 265-265
[2]  
Caen J P(1997) cord blood cells: comparative studies with transforming growth factor beta1 Blood 89 2328-2328
[3]  
Fournier S(1995)Platelet factor 4 and other CXC chemokines support the survival of normal hematopoietic cells and reduce the chemosensitivity of cells to cytotoxic agents Bull Acad Natl Med 179 1657-1657
[4]  
Han Z C(2000)Platelet factor 4, reversible inhibitor of megakaryocytogenesis, protector of megakaryocytes during chemotherapy Nature 404 725-725
[5]  
Lu M(1998)Specificities of heparan sulphate proteoglycans in developmental processes Blood 92 4641-4641
[6]  
Li J(2002)Structurally specific heparan sulfates support primitive human hematopoiesis by formation of a multimolecular stem cell niche J Cell Physiol 168 97-97
[7]  
Caen J P(2000)Glycosaminoglycans enhance megakaryocytopoiesis by modifying the activities of hematopoietic growth regulators Blood 95 147-147
[8]  
Xi X(undefined)Human LTC-IC can be maintained for at least 5 weeks in vitro when interleukin-3 and a single chemokine are combined with O-sulfated heparan sulfates: requirement for optimal binding interactions of heparan sulfate with early-acting cytokines and matrix proteins undefined undefined undefined-undefined
[9]  
Aidoudi S(undefined)undefined undefined undefined undefined-undefined
[10]  
Perrimon N(undefined)undefined undefined undefined undefined-undefined